A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS

Conditions:   Multiple Sclerosis;   Spasticity, Muscle Interventions:   Drug: Arbaclofen;   Drug: Placebo Sponsor:   Osmotica Pharmaceutical US LLC Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Study